Accreditation

Continuing Medical Education Information

 

AACE Endocrine University

EU Y1 Event start date: 02/24/2022
Credit claim deadline: 12/31/2022

 

Statement of Need

Endocrine University® is designed to provide a forum for endocrinology Fellows-in-Training to enhance their endocrine curriculum, particularly in diabetes, thyroid, bone, and new technology which has become essential to the practice of endocrinology.

 

Target Audience

This program is intended for first year endocrine Fellows-in-Training.

 

Learning Objectives

By the end of the meeting, participants will be able to:

  • Effectively utilize new skills and technology in diabetes and thyroid ultrasound.
  • Apply the most up-to-date guidelines and evidence-based practices for the diagnosis and treatment of diabetes and thyroid disease.
  • Integrate the latest evidence-based research for diagnosis and treatment of emerging areas of diabetes, thyroid, and bone related practice.

 

Accreditation and Designation Statements

ACCME

The American College of Endocrinology (ACE) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. The American College of Endocrinology (ACE) designates this Live activity for a maximum of 16 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure and Conflicts of Interest Policy:

American Association of Clinical Endocrinology (AACE) remains strongly committed to providing the best available evidence-based clinical information to participants of this educational activity and requires an open disclosure of any potential conflict of interest identified by our faculty members. It is not the intent of AACE to eliminate all situations of potential conflict of interest, but rather to enable those who are working with AACE to recognize situations that may be subject to question by others. All disclosed conflicts of interest are reviewed by the CME Subcommittee to ensure that such situations are properly evaluated and, if necessary, resolved. AACE educational standards pertaining to conflict of interest are intended to maintain the professional autonomy of the clinical experts inherent in promoting a balanced presentation of science. Through our review process, all AACE accredited activities are ensured of independent, objective, scientifically balanced presentations of information. Disclosure of any or no relationships will be made available for all educational activities.

Planners

None of the planners for this educational activity have relevant financial relationships to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling or distributing healthcare products used by or on patients.

 

Faculty Disclosures

Name Relevant Financial Relationship  Ineligible Company  
Naifa Busaidy, MD Consulting Fees Exelixis; Eisai 
Daniel DeSalvo, MD Honoraria, Consulting Fees Dexcom 
 Research Grant Insulet  
Mimi Hu, MD Honoraria, Consulting Fees, Contracted Research Blueprint Medicines; Eli Lily   
 Consulting Fees  Veracyte 
Silvio Inzucchi, MD Consulting Fees Abbott; AstraZeneca; Lexicon; Esperion; Merck; Novo Nordisk; Pfizer; vTv Pharma; Boehringer Ingelheim 
 Clinical Trial Publications Committee Boehringer Ingelheim 
Marie McDonnell, MD Research Grant Eli Lilly 
 Consulting Fees  Everlywell, Inc 
Nadine Palermo, DO Research Support DexCom 
Richard Pratley, MD Consulting Fees - Paid directly to AdventHealth Bayer AG; Corcept Therapeutics Inc.; Dexcom; Hanmi Pharmaceutical Co.; Merck; Pfizer; Sanofi; Sun Pharmaceutical Industries 
 Novo Nordisk Research Grant - Paid directly to AdventHealth 
Archana Sadhu, MD Consulting Fees Abbott 
Elias Siraj, MD Honoraria Boehringer Ingelheim; Eli Lilly; Novo Nordisk 
 Consulting Fees Boehringer Ingelheim; Eli Lilly; Novo Nordisk 
Brett Stacey, MD Research Grant  Nevro  
Dace Trence, MD Stockholder/Ownership Interest Medtronic; Sanofi 
Guillermo E. Umpierrez, MD University Grants/Research Support AstraZeneca; Dexcom 

 

All other faculty for this educational activity have no relevant financial relationships to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

 

Reviewers

None of the reviewers for this educational activity have relevant financial relationships to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling or distributing healthcare products used by or on patients.

 

Commercial Supporters

This activity is supported by independent educational grants from:

  • Abbott Diabetes Care
  • Amgen
  • Corcept Therapeutics
  • Lilly
  • Medtronic
  • Novo Nordisk Inc.
  • Pfizer Inc.
  • Pfizer-Merck Alliance
  • Radius Health, Inc.
  • Recordati Rare Diseases
  • Ultragenyx Pharmaceutical Inc.